FDA Investigator Tiara Nbrown Crosen

Tiara Nbrown Crosen has conducted inspections on 65 sites in 10 countries as of 13 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
65
Last Inspection Date:
13 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, China, India, Mexico, Hungary, Puerto Rico, Switzerland, Slovakia, Italy, Sweden
FDA Investigators that have inspected at least one site in common with Tiara Nbrown Crosen:
Ademola O Daramola, Aditi S Thakur, Adree N Anderson, Allison E Sincek, Amanda L Fyles, Amy E Devine, Ana P Pineda Zavaleta, Ana Paulap Sandee, Anastasia G Lolas, Andy B Lee, Angela E Glenn, Anissa M Vargas, Anna Lazar, Anthony R Bucks, Aqualia L Nelson, Arie C Menachem, Arindam Dasgupta, PhD, Arlene M Badillo, Ashutosh Rao, PhD, Avery J Dennis, Azza Talaat, Bei Y He, Binh T Nguyen, Bo Chi, PhD, Brandon C Heitmeier, Brent M Dehaan, Brett R Havranek, Brittany D Terhar, Bryan A Galvez, Carl A Huffman, III, Carlos A Medina, Carrie A Hughes, Caryn M Mcnab, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles M Edwards, Cheryl A Clausen, Chiang Syin, PhD, Christine W Twohy, Christopher M Jenner, Cody D Rickman, Corey K Reno, Courtney E Hillier, Cynthia Jim, CSO, Cynthia M Goudeau, Danial S Hutchison, Darrah, Darren S Brown, David L Miser, David M Beltran, Dawn C Olenjack, Deborah J Parris, Dell S Moller, Dennis Cantellops Paite, Dewayne E Whitlock, Diana K Krepel, Dipesh K Shah, Dogbeda F Mackenzie, Dr. Carmelo Rosa, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Zhihao Qiu (Peter), PhD, Dustin M James, Dwight D Ferguson, Edward E Lockwood (EEL), Edward P Potter, Edwin Melendez, Elizabeth L Holmes, Eric C Nielsen, Eric L Dong, BS, Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Esther B Gamallo Herrera, Farhana Khan, Felix Maldonado, Frances Namuswe, PhD, Gary R Wong, Gayle S Lawson, Gene R Gunn, George R Smith, Gerald B Seaborn, Jr, Gloria J Champagne, Gretchen Lf Trendel, Guerlain Ulysse, Gunneet Kaur, Gwyn G Dickinson, Herbert M Corbello, Heriberto Negron Rivera, Isabel Y Espinosa, Ivis L Negron, James C Maclaughlin, James I Giefer, James P Mcreavey, Jane S Wernberg, Janna C Hutchinson, Javier O Vega, Jawaid Hamid, Jeffery A Hangartner, Jeffrey P Raimondi, Jennifer M Gogley, Jill J Tillman, Joey V Quitania, Jogy George, John A Gonzalez, John A Iwen, Jonathan R Campos, Jorge L Guadalupe, Jose Acruz Gonzalez, José E Meléndez, Jose R Lopez, Jose Velez, Joselin P Baray Alvarado, Joseph A Piechocki, Joseph R Lambert, Juhong Liu, PhD, June P Page, Junho Pak, Justin A Boyd, Kara L Roden, Karen C Daugherty, Katherine Szestypalow, Kathleen B Swat, Kathleen J Close, Kathy Kuo, Keeshunna D Daniels, Kelley, Kellia N Hicks, Kelvin X Sanders, Kenneth H Williams, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kristi M Hampton Thurston, Kristin M Abaonza, Laiza V Garcia, Lakecha N Lewis, LCDR Ismael Olvera, IV, Lewis K Antwi, Libia M Lugo, Lillian S Wu, Liming Zhang, Linda Thai, Lindsey M Schwierjohann, Linhart, Lisa L Flores, Lisa R Hilliar, Lori B Wikstrom, Louis S Chen, LT Richard A Lyght, Madushini Dharmasena, PhD, Margarita Santiago, Maria Joselopez Barragan, PhD, Marion Michaelis, Mark G Peterson, Mary E Storch, Mary L Schuckmann, Matthew B Casale, Matthew J Johnson, Matthew M Schuckmann, Maya M Davis, Melissa M Steiger, Meredith P Soehl, Investigator, Michael A Charles, Michael D Garcia, Michael D Porter, Michael L Casner, Michael P Sheehan, Michael R Goga, Michael Shanks, MS, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Mindy M Chou, Minerva Rogers, Monica E Murie, Mra Davism, Mra M Barbosar, Muralidhara B Gavini, PhD, Myra K Casey, Nadeem I Chaudhry, Nancy G Schmidt, Nebil A Oumer, Noreen Muñiz, Omotunde O Osunsanmi, Pamela L Velez Vega, Paranthaman Senthamaraikannan, Patrick C Klotzbuecher, Patrick L Wisor, Paul A Bonneau, Peter E Baker, Peter E Gruman, Philip J Boston, Rafael E Arroyo, Rafael Nevarez Nieves, Rafeeq A Habeeb, Ralph A Erickson, Ramon A Hernandez, Randy D Baxter, Raymond T Anderson, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Rita K Kabaso, Robert C Coleman, Robert J Ham, Robert M Barbosa, Robert Rodriguez, Rochelle K Kimmel, Roger F Zabinski, Rumany C Penn, PharmD, Russell K Riley, Ryan J Borges, Samantha J Bradley, Santos E Camara, Sarah E Rhoades, Scott A Jepson, Scott N Lim, Scott T Ballard, Shafiq S Ahadi, Shanna R Haden, Sharon K Thoma, PharmD, Shaun M Olson, Shererk, Sherry G Bous, Shirley J Berryman, Simone E Pitts, Sina Shojaee, Sonia M Monges, Stacie A Woods, Stephanie A Slater, MS, Steven A Gonzales, Steven D Kehoe, Steven P Allen, Steven P Donald, Sue Lee Chan, Sundy V Sedwick, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Susanne M Richardson, MS RAC, Taichun Qin, PhD, Tamala P Bogan, Tamala P Magee, Tamara J Umscheid, Tamil Arasu, PhD, Ted L Anderson, Teresa T Cain, Thao T Kwan, Theressa B Smith, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tonya R Johnson, Torrey M Ward, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Valeria A Moore, Victoria A Wagoner, Vioela J Caze, Virgilio F Pacio, CSO, Vivin George, Vlada Matusovsky, Walden H Lee, Walsworth, Wayne D Mcgrath, Wayne E Seifert, Wayne W Grundstrom, Wen Ning Chan (Sally), William A Warnick, William Hallett, PhD, William J Leonard, William Suminski, Xiaokuang Lai, PhD, Xiaoping Guan, Ying Xin Fan, PhD, Youkeun Kim, Young M Choi, PhD, Yumi J Hiramine, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Tiara Nbrown Crosen's Documents

Publish Date Document Type Title
March, 2018 FDA 483 Fujian Kerui Pharmaceutical Co., Ltd. - Form 483, 2018-03-16
September, 2018 FDA 483 HomeChoice Partners, Inc. dba Bioscrip Infusion Services - Form 483, 2018-09-19
November, 2018 FDA 483 Lee Pharma Ltd. - Form 483, 2018-11-02
August, 2016 EIR Roquette America, Inc. - EIR, 2016-08-03
June, 2023 FDA 483 ALS Group USA, Corp. - Form 483, 2023-06-05
August, 2015 EIR Jost Chemical Co. - EIR, 2015-08-24
November, 2016 EIR R.D. Laboratories, Inc. - EIR, 2016-11-02
September, 2017 FDA 483 Dolan Central Illinois Compounding LLC dba Preckshot Professional Pharmacy - Form 483, 2017-09-19
November, 2015 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2015-11-20
November, 2016 FDA 483 SpecGx LLC - Form 483, 2016-11-22
March, 2016 FDA 483 SpecGx LLC - Form 483, 2016-03-07
September, 2023 FDA 483 Michelson Laboratories, Inc. - Form 483, 2023-09-26
June, 2018 FDA 483 BIOTIKA a.s. - Form 483, 2018-06-01
September, 2016 FDA 483 Alkem Laboratories Limited - Form 483, 2016-09-29
April, 2019 FDA 483 Sentio BioSciences LLC - Form 483, 2019-04-19
August, 2018 FDA 483 Wuhan Biocause Pharmaceutical Development Co.,Ltd - Form 483, 2018-08-24
March, 2017 FDA 483 Alcami Carolinas Corporation - Form 483, 2017-03-28
January, 2017 FDA 483 Vi-Jon, LLC - Form 483, 2017-01-11
September, 2015 EIR ALI Pharmaceutical Manufacturing, LLC - EIR, 2015-09-04
December, 2017 FDA 483 Lonza AG - Form 483, 2017-12-15
November, 2017 FDA 483 SSM Health Care St. Louis DBA SSM St. Clare Health Center - Form 483, 2017-11-16
March, 2022 FDA 483 General Air Service & Supply Co. - Form 483, 2022-03-25
November, 2018 FDA 483 BAL PHARMA LIMITED - Form 483, 2018-11-16
March, 2017 EIR Alcami Carolinas Corporation - EIR, 2017-03-28
December, 2015 FDA 483 Camco Chemicals Company Inc - Form 483, 2015-12-09
November, 2016 EIR SpecGx LLC - EIR, 2016-11-22
October, 2023 FDA 483 THE HAIN CELESTIAL GROUP INC - Form 483, 2023-10-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more